Wang et al. designed a tumor-targeted oncolytic adenovirus (Ad-TD) to deliver non-secreting IL-12 (nsIL-12) to peritoneally disseminated and orthotopic pancreatic tumors [37]. Here, SPRR2A is linked to neoplasm.